Physician
Kassicieh, Samir
Kassicieh, Samir was paid $1.11M by Medicaid between Jan 2018 and Aug 2022, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoKASSICIEH, SAMIR
ALBUQUERQUE, NM 87105
ALBUQUERQUE, NM 87105
33aNPI1730254350assigned 11/21/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.11M
24GClaims62,945
24DCodes billed79
24AFirst – last monthJan 2018 – Aug 2022
Compared with peers
Next to other Family Medicine Physician providers in New Mexico
Rank by total paid#30 of 148
Median peer was paid$167K
This provider vs. median6.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,342 | $347K | |
| 2019 | 11,533 | $223K | |
| 2020 | 18,973 | $211K | |
| 2021 | 13,703 | $188K | |
| 2022 | 9,394 | $142K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 6,787 | 6,210 | $369K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 3,631 | 3,430 | $274K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 6.2% | 663 | 647 | $68K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 5.2% | 600 | 598 | $58K |
| 99401 | 4.0% | 1,640 | 1,551 | $44K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.6% | 1,119 | 960 | $40K |
| 93922 | 3.2% | 538 | 536 | $36K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.1% | 2,436 | 2,025 | $35K |
| 99205 | Prolong outpt/office vis | 2.5% | 169 | 169 | $28K |
| 95923 | 2.3% | 296 | 295 | $26K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.2% | 159 | 159 | $24K |
| 80305 | 2.0% | 2,094 | 2,056 | $22K |
67 more codes
| 99497 | 1.8% | 378 | $20K | |
| 93923 | <1% | 84 | $9K | |
| 82962 | <1% | 2,830 | $6K | |
| 99490 | Ccm add 20min | <1% | 406 | $5K |
| 95943 | <1% | 77 | $5K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 43 | $4K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 371 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 174 | $4K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 114 | $4K |
| 80306 | <1% | 197 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 152 | $2K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 76 | $2K |
| J2010 | Injection, lincomycin hcl, up to 300 mg | <1% | 199 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 891 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 47 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 13 | $1K |
| 99173 | <1% | 45 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 680 | $1K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 14 | $1K |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 31 | $809.67 |
| 90688 | <1% | 58 | $790.61 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 569 | $789.89 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 16 | $713.70 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $542.76 |
| 81002 | <1% | 201 | $436.95 | |
| 97032 | <1% | 30 | $369.39 | |
| 90656 | <1% | 17 | $296.10 | |
| 90686 | <1% | 14 | $251.40 | |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | <1% | 15 | $216.89 |
| 92551 | <1% | 17 | $203.83 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 25 | $201.00 |
| 82270 | <1% | 50 | $155.57 | |
| 94760 | <1% | 203 | $131.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 259 | $130.71 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 23 | $50.12 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 15 | $47.06 |
| 96116 | <1% | 12 | $38.32 | |
| 99000 | <1% | 76 | $9.32 | |
| G0008 | Administration of influenza virus vaccine | <1% | 12 | $0.23 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 901 | $0.00 |
| 4040F | 0% | 1,745 | $0.00 | |
| 4005F | 0% | 302 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 2,397 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 5,302 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 3,639 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 1,214 | $0.00 |
| 3046F | 0% | 146 | $0.00 | |
| G8399 | Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed | 0% | 415 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 0% | 637 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 861 | $0.00 |
| 3051F | 0% | 42 | $0.00 | |
| 3078F | 0% | 36 | $0.00 | |
| 3048F | 0% | 231 | $0.00 | |
| 3008F | 0% | 2,419 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 2,146 | $0.00 |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 256 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 5,749 | $0.00 |
| 3017F | 0% | 3,977 | $0.00 | |
| 3044F | 0% | 681 | $0.00 | |
| 1111F | 0% | 203 | $0.00 | |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 200 | $0.00 |
| G8430 | Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status) | 0% | 28 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 754 | $0.00 |
| G9716 | Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason | 0% | 21 | $0.00 |
| 3061F | 0% | 14 | $0.00 | |
| 3074F | 0% | 34 | $0.00 | |
| 3049F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.